CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		3,944,000
Beginning balance at Dec. 31, 2022	$ (2,066)	$ 0	$ 83,804	$ (85,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		50,000
Issuance of warrants in connection with Credit Agreement amendment	4,060		4,060
Repurchase of restricted stock for payroll tax withholding (in shares)		(12,000)
Repurchases of restricted stock for payroll tax withholding	(163)		(163)
Stock-based compensation expense	2,090		2,090
Net loss	(10,545)			(10,545)
Ending balance (in shares) at Mar. 31, 2023		3,982,000
Ending balance at Mar. 31, 2023	$ (6,624)	$ 0	89,791	(96,415)
Beginning balance (in shares) at Dec. 31, 2023	4,072,713	4,073,000
Beginning balance at Dec. 31, 2023	$ (27,992)	$ 0	94,544	(122,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		55,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(22,000)
Repurchases of restricted stock for payroll tax withholding	(312)		(312)
Stock-based compensation expense	1,391		1,391
Net loss	$ (570)			(570)
Ending balance (in shares) at Mar. 31, 2024	4,105,645	4,106,000
Ending balance at Mar. 31, 2024	$ (27,483)	$ 0	$ 95,623	$ (123,106)